Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2012

Open Access 01-12-2012 | Research

Tobacco taxation: the importance of earmarking the revenue to health care and tobacco control

Authors: Constantine I Vardavas, Filippos T Filippidis, Israel Agaku, Vasileios Mytaras, Monique Bertic, Gregory N Connolly, Yannis Tountas, Panagiotis Behrakis

Published in: Tobacco Induced Diseases | Issue 1/2012

Login to get access

Abstract

Background

Increases in tobacco taxation are acknowledged to be one of the most effective tobacco control interventions. This study aimed at determining the mediating role of socioeconomical status (SES) and the earmarking of revenue to healthcare and tobacco control, in influencing population support for the adoption of a 2 Euro tobacco tax increase in Greece, amid the challenging economic environment and current austerity measures.

Methods

Data was collected from two national household surveys, the “Hellas Health III” survey, conducted in October 2010 and the "Hellas Tobacco survey” conducted in September 2012. Data was analyzed from 694 and 1066 respondents aged 18 years or more, respectively. Logistic regression models were fitted to measure the adjusted relationship between socio-economic factors for the former, and support for increased taxation on tobacco products for the latter.

Results

In 2012 amidst the Greek financial crisis, population support for a flat two euro tax increase reached 72.1%, if earmarked for health care and tobacco control, a percentage high both among non-smokers (76%) and smokers (64%) alike. On the contrary, when not earmarked, only 43.6% of the population was in support of the equivalent increase. Women were more likely to change their mind and support a flat two-euro increase if the revenue was earmarked for health care and tobacco control (aOR = 1.70; 95% C.I: 1.22-2.38, p = 0.002). Furthermore, support for an increase in tobacco taxation was not associated with SES and income.

Conclusion

Despite dire austerity measures in Greece, support for an increase in tobacco taxation was high among both smokers and non-smokers, however, only when specifically earmarked towards health care and tobacco control. This should be taken into account not only in Greece, but within all countries facing social and economic reform.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference International Agency for Research on Cancer: Effectiveness of Tax and Price Policies for Tobacco Control - IARC Handbooks of Cancer Prevention Volume 14. 2011, Lyon, France: International Agency for Research on Cancer International Agency for Research on Cancer: Effectiveness of Tax and Price Policies for Tobacco Control - IARC Handbooks of Cancer Prevention Volume 14. 2011, Lyon, France: International Agency for Research on Cancer
3.
go back to reference Ross H, Blecher E, Lili Yan L, Hyland A: Do cigarette prices motivate smokers to quit? New evidence from the ITC survey. Addiction. 2011, 106 (3): 609-619. 10.1111/j.1360-0443.2010.03192.x.PubMedCentralCrossRefPubMed Ross H, Blecher E, Lili Yan L, Hyland A: Do cigarette prices motivate smokers to quit? New evidence from the ITC survey. Addiction. 2011, 106 (3): 609-619. 10.1111/j.1360-0443.2010.03192.x.PubMedCentralCrossRefPubMed
4.
go back to reference Chaloupka FJ, Straif K, Leon ME, Working Group, International Agency for Research on Cancer: Effectiveness of tax and price policies in tobacco control. Tob Control. 2011, 20 (3): 235-238. 10.1136/tc.2010.039982.CrossRefPubMed Chaloupka FJ, Straif K, Leon ME, Working Group, International Agency for Research on Cancer: Effectiveness of tax and price policies in tobacco control. Tob Control. 2011, 20 (3): 235-238. 10.1136/tc.2010.039982.CrossRefPubMed
5.
go back to reference Chaloupka FJ, Hu TW, Warner KE: The Taxation of Tobacco Products. Tobacco Control in Developing Countries. Edited by: Jha P, Chaloupka FJ. 2000, Oxford: Oxford University Press, 237-72. Chaloupka FJ, Hu TW, Warner KE: The Taxation of Tobacco Products. Tobacco Control in Developing Countries. Edited by: Jha P, Chaloupka FJ. 2000, Oxford: Oxford University Press, 237-72.
6.
go back to reference Ross H, Chaloupka FJ: Economic policies for tobacco control in developing countries. Salud Publica Mex. 2006, 48: S113-20.CrossRefPubMed Ross H, Chaloupka FJ: Economic policies for tobacco control in developing countries. Salud Publica Mex. 2006, 48: S113-20.CrossRefPubMed
7.
go back to reference Filippidis FT, Vardavas CI, Loukopoulou A, Behrakis P, Connolly GN, Tountas Y: Prevalence and determinants of tobacco use among adults in Greece: 4 year trends. Eur J Public Health. 2012, (in press) Filippidis FT, Vardavas CI, Loukopoulou A, Behrakis P, Connolly GN, Tountas Y: Prevalence and determinants of tobacco use among adults in Greece: 4 year trends. Eur J Public Health. 2012, (in press)
8.
go back to reference Gardner B, West R: Public support in England for raising the price of cigarettes to fund tobacco control activities. Tob Control. 2010, 19 (4): 331-3. 10.1136/tc.2009.033274.CrossRefPubMed Gardner B, West R: Public support in England for raising the price of cigarettes to fund tobacco control activities. Tob Control. 2010, 19 (4): 331-3. 10.1136/tc.2009.033274.CrossRefPubMed
9.
go back to reference Kotz D, West R: Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding. Tob Control. 2009, 18: 43e6.CrossRef Kotz D, West R: Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding. Tob Control. 2009, 18: 43e6.CrossRef
11.
go back to reference Licht AS, Hyland AJ, O'Connor RJ, Chaloupka FJ, Borland R, Fong GT, Nargis N, Cummings KM: Socio-economic variation in price minimizing behaviors: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011, 8 (1): 234-52. 10.3390/ijerph8010234.PubMedCentralCrossRefPubMed Licht AS, Hyland AJ, O'Connor RJ, Chaloupka FJ, Borland R, Fong GT, Nargis N, Cummings KM: Socio-economic variation in price minimizing behaviors: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011, 8 (1): 234-52. 10.3390/ijerph8010234.PubMedCentralCrossRefPubMed
13.
go back to reference Krasovsky KS: "The lobbying strategy is to keep excise as low as possible" - tobacco industry excise taxation policy in Ukraine. Tob Induc Dis. 2010, 8: 10-10.1186/1617-9625-8-10.PubMedCentralCrossRefPubMed Krasovsky KS: "The lobbying strategy is to keep excise as low as possible" - tobacco industry excise taxation policy in Ukraine. Tob Induc Dis. 2010, 8: 10-10.1186/1617-9625-8-10.PubMedCentralCrossRefPubMed
15.
go back to reference Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D: Health effects of financial crisis: omens of a Greek tragedy. Lancet. 2011, 378 (9801): 1457-8. 10.1016/S0140-6736(11)61556-0.CrossRefPubMed Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D: Health effects of financial crisis: omens of a Greek tragedy. Lancet. 2011, 378 (9801): 1457-8. 10.1016/S0140-6736(11)61556-0.CrossRefPubMed
Metadata
Title
Tobacco taxation: the importance of earmarking the revenue to health care and tobacco control
Authors
Constantine I Vardavas
Filippos T Filippidis
Israel Agaku
Vasileios Mytaras
Monique Bertic
Gregory N Connolly
Yannis Tountas
Panagiotis Behrakis
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2012
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-10-21

Other articles of this Issue 1/2012

Tobacco Induced Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.